hotspot -WSS

hotspot

author：comprehensive 2025-10-02 19:38:35 - browse：7952

insulin biosimilar — Last week, the FDA released a trio of guidelines clarifying the way they plan to evaluate devices that go through the 510(k) pathway. Jacquelyn Martin/AP

Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, the Food and Drug Administration has issued new guidelines to improve its so-called 510(k) program that has long been lambasted for letting risky devices fall through the cracks.

Most medical device companies do not have to test their products on people in order to secure clearance from the FDA — they simply have to show they’re “substantially equivalent” to devices already on the market, called “predicates.” This process is the 510(k) pathway, and accounts for the vast majority of new medical devices launched on the market each year. Devices cleared through this pathway include X-ray machines, muscle stimulators, and wheelchairs.

Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices that were recalled due to a “design-related” issue or have “unmitigated” safety concerns. Manufacturers should submit flow charts explaining why they chose their predicate device. If they have to choose one with a recall history or safety issues, they should explain how the new device addresses those problems. The FDA may also ask the manufacturer for clinical data in this case.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： White House drug shortages task force keeps mum with Congress

leisure time

WSS

Acelyrin, a rare IPO success, stumbles in its first big test

Maui funeral service workers on devastation of fires: 'I'm in shock'

Telehealth for opioid use disorder is lifesaving

Pharma budget tightening trickles down to Doximity

Faced with fears of OxyContin misuse, sales reps touted its safety

Walmart eyes Medicare Advantage provider ChenMed

explore

hotspot

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Hospitals consider fixing cancer drug shortages on their own

Malaria cases in Florida and Texas: Here’s what you need to know

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Hepatitis C has a cure — but many Americans still lack access to it

Maui funeral service workers on devastation of fires: 'I'm in shock'

Alkermes shareholders re

TB outbreak tied to bone grafts underscores testing shortcomings

entertainment

FDA approves updated Covid vaccines

Will the IRA bring competition to the biologics market?

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

FDA approves updated Covid vaccines

Faced with fears of OxyContin misuse, sales reps touted its safety

CDC overhauls leadership of center that led response to Covid

leisure time

knowledge

entertainment

Wikipedia